Compare ORGO & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORGO | SPT |
|---|---|---|
| Founded | 1985 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.6M | 327.6M |
| IPO Year | 2016 | 2019 |
| Metric | ORGO | SPT |
|---|---|---|
| Price | $2.27 | $5.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | $8.50 | ★ $12.38 |
| AVG Volume (30 Days) | 1.0M | ★ 1.5M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | 32.11 |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $564,169,000.00 | $457,547,000.00 |
| Revenue This Year | N/A | $8.86 |
| Revenue Next Year | $26.27 | $8.04 |
| P/E Ratio | $14.94 | ★ N/A |
| Revenue Growth | ★ 17.04 | 12.72 |
| 52 Week Low | $2.21 | $5.37 |
| 52 Week High | $7.08 | $24.74 |
| Indicator | ORGO | SPT |
|---|---|---|
| Relative Strength Index (RSI) | 29.84 | 38.02 |
| Support Level | N/A | $5.39 |
| Resistance Level | $2.51 | $7.39 |
| Average True Range (ATR) | 0.13 | 0.30 |
| MACD | 0.03 | 0.08 |
| Stochastic Oscillator | 22.62 | 24.81 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.